Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)

SHE:301408 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	780.71	999.69	1,336	482.1	284.51	206.02
Short-Term Investments	-	-	-	-	-	20
Trading Asset Securities	81.2	10	12.41	-	0.5	5
Cash & Short-Term Investments	861.91	1,010	1,349	482.1	285.01	231.02
Cash Growth	-27.89%	-25.14%	179.76%	69.16%	23.37%	28.45%
Accounts Receivable	543.75	472.6	513.14	470.77	294.32	220.83
Other Receivables	64.78	44.12	36.24	34.52	30.82	27.07
Receivables	608.53	516.73	549.38	505.29	325.14	247.9
Inventory	1,030	863.84	772.09	545.01	436.19	302.96
Prepaid Expenses	-	15.63	8.27	2.52	4.22	63.48
Other Current Assets	207.92	191.49	147.78	165.22	62.74	79.31
Total Current Assets	2,708	2,597	2,826	1,700	1,113	924.68
Property, Plant & Equipment	1,001	967.8	870.15	533.42	542.53	49.62
Long-Term Investments	45.52	82.2	92.81	25.45	8.92	1.9
Goodwill	1,355	988.37	609.31	190.06	190.06	153.11
Other Intangible Assets	64.65	67.21	62.51	33	8.26	7.34
Long-Term Deferred Tax Assets	49.06	40.65	32.83	21.92	15.17	5.66
Long-Term Deferred Charges	84.65	59.03	52.11	58.97	92.32	126.04
Other Long-Term Assets	61.14	25.48	65.74	13.23	0.5	17.88
Total Assets	5,369	4,828	4,612	2,576	1,971	1,286
Accounts Payable	1,541	1,158	1,027	698.74	468.23	370.94
Accrued Expenses	60.22	140.25	99.84	101.68	79.98	61.32
Short-Term Debt	309.4	316.92	513.51	340.31	150.77	111.12
Current Portion of Long-Term Debt	406.63	116.02	10.25	-	-	-
Current Portion of Leases	-	210.44	193.64	154.24	144	-
Current Income Taxes Payable	33.28	20.63	12.3	34.63	13.15	4.87
Current Unearned Revenue	38.58	37.11	27.06	19.41	11.25	9.94
Other Current Liabilities	105.54	178.94	80.31	12.7	15.25	12.59
Total Current Liabilities	2,495	2,179	1,964	1,362	882.64	570.79
Long-Term Debt	475.75	358.83	331.15	18.95	-	-
Long-Term Leases	217.04	222.85	237.65	248.51	303.03	-
Long-Term Unearned Revenue	1.71	0.81	0.91	-	-	-
Long-Term Deferred Tax Liabilities	6.37	6.65	6.32	-	-	-
Other Long-Term Liabilities	13.33	-	95.4	-	0.33	0.38
Total Liabilities	3,209	2,768	2,635	1,629	1,186	571.17
Common Stock	400.01	400.01	400.01	340	340	340
Additional Paid-In Capital	950.3	977.86	1,014	194.7	192.99	192.75
Retained Earnings	745.71	627.42	529.39	412.58	251.81	182.08
Total Common Equity	2,096	2,005	1,944	947.28	784.8	714.83
Minority Interest	64.06	55.14	33	-0.27	0.25	0.24
Shareholders' Equity	2,160	2,060	1,977	947.01	785.05	715.07
Total Liabilities & Equity	5,369	4,828	4,612	2,576	1,971	1,286
Total Debt	1,409	1,225	1,286	762.02	597.8	111.12
Net Cash (Debt)	-546.9	-215.36	62.53	-279.92	-312.8	119.9
Net Cash Growth	-	-	-	-	-	495.88%
Net Cash Per Share	-1.35	-0.53	0.16	-0.82	-0.94	0.35
Filing Date Shares Outstanding	400.01	400.01	400.01	340	340	340
Total Common Shares Outstanding	400.01	400.01	400.01	340	340	340
Working Capital	213.47	418.84	862.52	338.42	230.65	353.89
Book Value Per Share	5.24	5.01	4.86	2.79	2.31	2.10
Tangible Book Value	676.85	949.71	1,272	724.22	586.49	554.38
Tangible Book Value Per Share	1.69	2.37	3.18	2.13	1.72	1.63
Buildings	-	219.2	238.73	23.15	23.15	23.15
Machinery	-	297.24	270.16	79.38	65.74	52.52
Construction In Progress	-	168.66	61.34	32.24	0.25	0.87

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.